» Articles » PMID: 36631370

Association of Smoking History on Health-related Quality of Life in Patients Undergoing Radical Cystecomy

Overview
Journal Urol Oncol
Publisher Elsevier
Date 2023 Jan 11
PMID 36631370
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Radical cystectomy (RC) has the potential to impact health-related quality of life (HRQOL). Many patients who undergo RC are current or former smokers. To better inform preoperative patient counseling, we examined the association between smoking status and HRQOL after RC.

Materials And Methods: A secondary analysis was performed on a prospective, longitudinal study (2008-2014) examining HRQOL in patients undergoing RC for bladder cancer. We analyzed 12 validated patient-reported outcome measures that focused on functional, symptomatic, psychosocial, and global HRQOL domains. Measures were collected pre-operatively and 3-, 6-, 12-, 18-, and 24-months postoperatively. For each HRQOL domain, we estimated the mean domain scores using a generalized estimation equation linear regression model. Each model included survey time, smoking status, and time-smoking interaction as covariates. Pairwise comparisons of current, former, and never smokers were estimated from the models.

Results: Of the 411 patients available for analysis, 29% (n = 119) never smoked, 59% (n = 244) were former smokers, and 12% (n = 48) were current smokers. Over the follow-up period, never smokers compared to current smokers had better global QOL scores (mean difference = +8.9; 95% CI 1.3-16; p = 0.023) and lower pain levels (mean difference = -10; 95% CI -19 to -0.54; p = 0.036). Compared to current smokers, former smokers had marginal improvements in global QOL (+6.9 points) and pain (-7.5 points) during the follow-up period.

Conclusions: Current smokers reported worse HRQOL recovery in the 24-months after RC. These findings can be used to counsel patients who smoke on recovery expectations.

Citing Articles

Preoperative smoking and robot-assisted radical cystectomy outcomes & complications in multicenter KORARC database.

Choi J, Lee J, Hwang Y, Jeong B, Lee S, Ku J Sci Rep. 2024; 14(1):10550.

PMID: 38719836 PMC: 11078966. DOI: 10.1038/s41598-024-61005-6.


Bladder Cancer Survivors Who Do Not Smoke Have Better Longitudinal Health-Related Quality of Life Measures: An Assessment of the Comparative Effectiveness and Survivorship Health in Bladder Cancer (CEASE-BC) Study.

Kay H, Silver S, Smith A, Basak R, Shoenbill K, Usinger D J Urol. 2024; 212(1):87-94.

PMID: 38603576 PMC: 11193885. DOI: 10.1097/JU.0000000000003964.

References
1.
Rink M, Zabor E, Furberg H, Xylinas E, Ehdaie B, Novara G . Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Eur Urol. 2012; 64(3):456-64. DOI: 10.1016/j.eururo.2012.11.039. View

2.
Parker W, Toussi A, Tollefson M, Frank I, Thompson R, Zaid H . Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical Cystectomy. Urology. 2016; 94:96-101. DOI: 10.1016/j.urology.2016.03.049. View

3.
Land S, Toll B, Moinpour C, Mitchell S, Ostroff J, Hatsukami D . Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research. Clin Cancer Res. 2016; 22(8):1907-13. PMC: 4861174. DOI: 10.1158/1078-0432.CCR-16-0104. View

4.
Clements M, Atkinson T, Dalbagni G, Li Y, Vickers A, Herr H . Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort. Eur Urol. 2021; 81(3):294-304. PMC: 8891075. DOI: 10.1016/j.eururo.2021.09.018. View

5.
Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View